Digest Network Come funziona
Network
/
Società
Ce
Non verificato

Centauri Therapeutics Limited

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniIndustriaSalute

3 comunicati stampa

Guarda tutti i comunicati
10/03/2026
Industria
Oncologia
Salute
Igiene alimentare
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Farmaceutica
Biotecnologia
Centauri Therapeutics Granted FDA QIDP Status for CTX-187 Treatment of Gram-Negative Bacterial Infections
Fonte
Centauri Therapeutics Limited
Emittente
Business Wire
1.00
0
24/02/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Attrezzature medico-sanitarie
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Centauri Therapeutics Extends Series A to £30M With £6M Investment From AMR Action Fund to Support Progression of Lead Clinical Candidate
Fonte
Centauri Therapeutics Limited
Emittente
Business Wire
1.00
0
04/03/2025
Industria
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Centauri Therapeutics Selects First Clinical Candidate, for Immunotherapeutic Treatment of Gram-negative Bacterial Infections
Fonte
Centauri Therapeutics Limited
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0